Hanbetai Injection

Update: 30 October, 2023

Hanbetai Injection is a biosimilar to bevacizumab. It is indicated for the treatment of patients with metastatic colorectal cancer and advanced, metastatic or recurrent non-small cell lung cancer.


File format: PDF

Size: -

MD5 Checksum: 66620ECA8A577EA0A1FF3234225767C7

Publication date: 30 October, 2023

Downloads: -

PDF Link: Hanbetai Injection PDF

Also Manuals